Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Intelligence Hub
News
Changes
Search
Log in
Get Started
ILUVIEN (FLUOCINOLONE ACETONIDE) | LOERadar
Viewing data from:
Latest
2026-08-03
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
ILUVIEN
NDA
FLUOCINOLONE ACETONIDE | N201923 | ALIMERA SCIENCES INC
1 strength
2 unique patents
0 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Price Trends
VA FSS
Medicare B
DMF
Approvals
Label
Products
Patent Timeline
2 unique patents by expiration date
Expiring < 1yr (1)
Active (1)
Today
2027
2028
Today
8871241
Aug. 12, 2027
9849027
Nov. 7, 2028
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 0.19MG
RLD
2 patents
0 exclusivities
▴
IMPLANT;INTRAVITREAL | Approved: Sep 26, 2014
Patents (2)
· 2 use codes
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
8871241
Aug 12, 2027
—
—
Yes
—
—
9849027
Nov 7, 2028
—
—
Yes
U-708
TREATMENT OF CHRONIC NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT OF THE EYE
U-4157
THE TREATMENT OF DIABETIC MACULAR EDEMA (DME) IN PATIENTS WHO HAVE BEEN PREVIOUSLY TREATED WITH A COURSE OF CORTICOSTEROIDS AND DID HAVE A CLINICALLY SIGNIFICANT RISE IN INTRAOCULAR PRESSURE
—